Shattuck Labs Inc
NASDAQ:STTK
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.005
11.18
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one STTK stock under the Base Case scenario is 1.148 USD. Compared to the current market price of 1.005 USD, Shattuck Labs Inc is Undervalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Shattuck Labs Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for STTK cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Shattuck Labs Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Shattuck Labs Inc
Balance Sheet Decomposition
Shattuck Labs Inc
Current Assets | 98.7m |
Cash & Short-Term Investments | 90.1m |
Other Current Assets | 8.7m |
Non-Current Assets | 13m |
PP&E | 10.8m |
Other Non-Current Assets | 2.2m |
Current Liabilities | 12.4m |
Accounts Payable | 2.9m |
Accrued Liabilities | 7.9m |
Other Current Liabilities | 1.6m |
Non-Current Liabilities | 2.7m |
Other Non-Current Liabilities | 2.7m |
Earnings Waterfall
Shattuck Labs Inc
Revenue
|
6.4m
USD
|
Operating Expenses
|
-86.3m
USD
|
Operating Income
|
-79.9m
USD
|
Other Expenses
|
5.5m
USD
|
Net Income
|
-74.4m
USD
|
Free Cash Flow Analysis
Shattuck Labs Inc
USD | |
Free Cash Flow | USD |
As of the third quarter's end in 2023, the company reported a robust financial stance with $101.1 million in cash, investments, and equivalents. R&D expenses rose to $24.2 million, compared to the prior year's $18.9 million, while G&A expenses dropped to $5.1 million from $6.6 million. The net loss widened slightly to $27.5 million. Importantly, financial guidance reaffirms sufficient funds to end of 2024. In clinical developments, exciting data results are forthcoming for the CD47 agent 154 in AML and higher-risk MDS, with potential to be first to market pending outcomes of future trials.
What is Earnings Call?
STTK Profitability Score
Profitability Due Diligence
Shattuck Labs Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
Shattuck Labs Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
STTK Solvency Score
Solvency Due Diligence
Shattuck Labs Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Shattuck Labs Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
STTK Price Targets Summary
Shattuck Labs Inc
According to Wall Street analysts, the average 1-year price target for STTK is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.
Dividends
Current shareholder yield for STTK is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
STTK Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. The company is headquartered in Austin, Texas and currently employs 85 full-time employees. The company went IPO on 2020-10-09. The firm is engaged in the development of dual-sided fusion proteins. The firm has created an approach to immune modulation by designing biologics with structural characteristics. Compounds derived from its Agonist Redirected Checkpoint (ARC) platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the cluster of differentiation 47/signal regulatory protein alpha (CD47/SIRPa) checkpoint interaction to restore an anti-tumor immune response and to activate the cluster of differentiation 40 (CD40) costimulatory receptor to bolster an immune response. The firm's second product candidate, SL-279252, is designed to simultaneously inhibit the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction and activate the OX40 receptor.
Contact
IPO
Employees
Officers
The intrinsic value of one STTK stock under the Base Case scenario is 1.148 USD.
Compared to the current market price of 1.005 USD, Shattuck Labs Inc is Undervalued by 12%.